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ABSTRACT

AlSharif, Sarah Saad. M.S. Microbiology and Immunology Graduate Program, Wright State
University, 2015. The Impact of HSV-1 Infection on Cell Viability, Morphology, and CD Markers
Expression by Unpolarized and Cytokine-Polarized J774A.1 Mouse Macrophages
Macrophages play an important role in the immune system, particularly in neutralizing
pathogens via phagocytosis and the production of multiple cytokines and chemokines that control
infection after exposure to specific stimuli. Macrophages exhibit two different phenotypes, M1
and M2. This study evaluated the role of Suppressors of cytokine signaling (SOCS)1 and SOCS3
on Herpes Simplex Virus (HSV-1) infection of polarized macrophages, cell viability, cell
morphology, and the expression of cell surface CD markers. I hypothesized that J774A.1 murine
macrophages cells in the naïve state (M0), and M1 and M2 phenotypes would display differences
in CD markers CD80,CD163, and CD200R, cell morphology, and viability following HSV1infection and that the SOCS3 peptide mimetic would reduce the cytotoxicity associated with the
M1 phenotype or HSV-1 infection.
Unpolarized J774A.1 macrophages (M0) or polarized M1 and M2 phenotypes displayed
differences in CD surface proteins at 18, 24, and 48 hours following HSV-1 infection and there
was ~22% decrease in viability in M1 macrophages regardless of whether the macrophages were
uninfected or infected with HSV-1. M2 macrophages demonstrated ~10% reductions in viability
compared with infected M0 macrophage. Differences in cell morphology were noticed in
uninfected polarized and unpolarized cells. M1 macrophages displayed irregular shapes and
intracellular vacuoles were more pronounced at 24 and 48 hours compared to 18 hours. M0
appeared rounded or elongated, and M2 macrophages induced by IL-4, IL-10, or IL-13 showed
iii

elongation with the majority of cells appearing rounded. HSV-1-infected M0, M1 or M2
macrophages all became rounded and aggregated following HSV-1 infection.
We found CD80 expression (by flow cytometry) was slightly deceased on uninfected M1
macrophages and M2 macrophages compared to uninfected M0 macrophages and infected M1
macrophages and IL-10-induced M2 macrophages also exhibited a minor increase in CD80. A
reduction of CD163 expression occurred on M1 macrophages uninfected or infected with HSV-1.
The level of CD163 on infected M2 macrophages was increased compared to uninfected M2
macrophage cells with the level being higher on infected IL-10-induced M2 macrophages. These
observations were not statistically significant; however, the level of CD200R significantly
increased on infected M2 macrophages polarized by IL-13 compared to CD200R expression in
virus-infected M0 macrophages.
Treatment with either SOCS3 peptide mimetic or pJAK2 increased the viability of
polarized J774A.1 M1 macrophages. Production of pro-inflammatory cytokines TNF-α and IL-6
were reduced in polarized M1 macrophage treated with SOCS3 or pJAK2 peptide mimetic
compared with polarized M1 untreated cells. Also, the SOCS3 peptide mimetic increased cell
viability in M1 and HSV-1-infected M1 RAW264.7 and J774A.1 macrophages, but this increase
was only significant in the RAW264.7 cells. This result suggests that SOCS3 mimetic exerts an
anti-inflammatory effect by diminishing the lytic effect of M1 polarization. M1 cells treated with
SOCS3 behave similar to the M2 phenotype and produce the anti-inflammatory cytokine IL-10.
This study highlights the events that lead to M1 versus M2 polarization and the knowledge gained
regarding SOCS3's ability to reduce inflammation may make it a potential therapeutic target for
inflammatory diseases.
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SPECIFIC AIMS and HYPOTHESIS

A previous study by Reichard (2012) showed that J774A.1 murine macrophages exhibited
variability in cell morphology, viability, and surface proteins expression 24 hours after exposure
to IL-4 or IFN-γ and LPS and /or HSV-1 infection. Based on these previous observations, in the
present study we evaluate the impact of HSV-1 on macrophages of different polarization
phenotypes and the impact of SOCS1 and SOCS3 during HSV-1 infection. Aim 1 is to
examine the effects of HSV-1 infection and macrophage polarization on cell viability, morphology,
and surface expression of CD80, CD163, and CD200R. We hypothesize that J774A.1 murine
macrophages cells in the naïve state (M0), and M1 and M2 phenotypes will display differences in
cell morphology, viability, and surface proteins at 18, 24, 48 hours following HSV-1infection.
Aim 2 is to quantitate cell viability and measure cytokine secretion for HSV-1-infected M1
macrophages supplemented with SOCS1, SOCS3, or phosphorylated-JAK2. We hypothesize that
a SOCS3 peptide mimetic will reduce the cytotoxicity associated with the M1 phenotype or HSV1 infection. Macrophages treated with either SOCS3 or SOCS1 inhibitor will produce more antiinflammatory cytokine (IL-10) and less pro-inflammatory cytokines (IL-6 and TNF-α) than
untreated M1 macrophages. We further anticipate that macrophages treated with SOCS1 will
increase the production of TNF-α.
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INTRODUCTION

Herpes simplex virus type 1 (HSV-1) is a member of the Herpesviridae family. It has a
double-stranded DNA genome packaged into an icosahedral protein capsid (Steven and Spear,
1997). HSV-1 is a highly significant virus in terms of its clinical relevance, infecting 70-80% of
the world’s adult population (Dakvist et. al., 1995). During the primary infection of HSV-1,
patients suffer from cold sores and fever blisters. Following the primary infection, the symptoms
tend to disappear as HSV-1 becomes latent in neurons of the dorsal root ganglia. Reactivation of
HSV-1 from latency leads to a relapse in symptoms (Sawtell, 1998; Spruance et. al., 1977). The
immune system, both the innate and adaptive arms, responds effectively to HSV-1 infection
through activation of macrophages, natural killer (NK) cells, and T cells that release a variety of
effector molecules. These molecules interfere with viral replication and help to control the
infection in host cells (Mogensen et. al., 1989).
Macrophages are derived from monocytes and play an important role in the immune
system, particularly in neutralizing pathogens via phagocytosis and the production of multiple
cytokines and chemokines that control infection and promote tissue healing (Mills, 2012).
Macrophages exhibit two different phenotypes after exposure to specific stimuli. These
phenotypes are referred to as M1 and M2 macrophages (Figure 1). Macrophages are able to convert
between the M1 and M2 phenotypes continuously in order to provide optimal macrophage
functioning and homeostasis during an inflammatory event (Stout et. al., 2005, Davis et. al., 2013).
M1 cells are induced by the combination of lipopolysaccharide (LPS) and the pro-inflammatory
cytokine interferon-γ (IFN-γ). These M1 cells produce high levels of pro-inflammatory effector
molecules such as interleukins (IL), including IL-1β, IL-6, IL-12, and IL-23, tumor necrosis factor
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(TNF), and inducible nitric oxide synthase (iNOS), which are vital in mediating cytotoxic
functions and contributing to host immune defenses (Figure 1). Over the course of these proinflammatory events, it is likely that even healthy tissue surrounding the infected area may be
damaged (Martinez and Gordon, 2014; Ding et. al., 1988). To help reduce the likelihood of
potential damage, stimulation with IL-4, IL-10, or IL-13 promotes macrophage polarization to the
M2 phenotype. The M2 phenotype has an anti-inflammatory effect by generating IL-10 and
transforming growth factor beta (TGF-β) (Mantovani et. al., 2004). These mediators participate in
wound healing, induce angiogenesis, and suppress immune responses (Novak and Koh, 2013)
(Figure 1).

Figure 1. Macrophage phenotypes have separate functions. M1 and M2 are converted from a naïve
state (M0) upon specific stimuli. M1 cells are induced by a variety of different stimuli, including
the combination of LPS and the pro-inflammatory cytokine IFN-γ. M1 macrophages are pro2

inflammatory and fight infection. M2 macrophages can be activated by IL-4, IL-10, or IL-13. M2
macrophages are anti-inflammatory and repair tissue damage. (Adapted from Nagy et al., 2012)
M1 and M2 macrophages can be distinguished by the cluster of differentiation (CD)
markers on their cell surface. Specifically, CD80, CD200R, and CD163, can differentiate between
M1 and M2 activated macrophages (Mantovani et. al., 2004). Based on a study done in human
monocyte-derived macrophages, Ambarus et al. (2012) found that CD80 expression levels were
specific to M1 macrophages; however, CD163 and CD200R were up-regulated in M2
macrophages induced by IL-10 and IL-4 or IL-13, respectively. These alterations in CD levels are
driven by the cells’ need to respond to the infection. CD80 acts as a co-stimulatory signal on the
surface of antigen presenting cells, activated B cells and monocytes. CD80 participates in T cell
initiation and maintenance (Linsley et. al., 1991). The CD200 receptor (CD200R) is responsible
for inhibiting inflammatory macrophage activation and is expressed on a number of immune cells
including myeloid cells, monocyte/macrophages, dendritic cells, and on certain T and B cells
(Hoek et. al., 2000). Both CD163 and CD200R are involved in anti-inflammatory actions that
serve to control the pro-inflammatory responses that may cause damage. They accomplish this by
decreasing the production of pro-inflammatory cytokines (Jenmalm et. al., 2006).
An additional layer of control over cytokine production comes in the form of the suppressor
of cytokine signaling (SOCS) proteins. SOCS proteins serve to negatively regulate cytokine
receptor signaling and toll-like receptors (TLR). For example, SOCS1 and SOCS3 are potent
inhibitors of the JAK/STAT pathway that ultimately activates the gene expression of proinflammatory molecules (Yoshimura et al., 2005). Therefore, the activity of SOCS proteins is
indirectly involved in the activation of macrophages to the M1 or M2 state, controlling which
cytokines are being produced (Wilson, 2014).
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LITERATURE REVIEW AND PRELIMINARY DATA

HSV-1
Herpes simplex virus type 1 (HSV-1) is a common virus that infects 70-80% of the adult
population (Dakvist et. al., 1995). In humans, the primary symptoms of active infections are sores
or lesions on mucosal surfaces or the skin. The virus establishes lifelong latency in neurons of the
dorsal root ganglia, during latency the infected individual does not display symptoms. During
stress or illness, latent HSV-1 infections can reactivate into an active infection and initiate cellular
damage and lysis, thereby causing the individual to develop symptoms again (Sawtell, 1998;
Spruance et. al., 1977).
HSV-1 is a member of the Herpesviridae family. It is a large DNA virus, consisting of a
linear, double-stranded DNA genome packaged into an icosahedral protein capsid and wrapped in
a lipid bilayer envelope (Steven and Spear, 1997). HSV infection utilizes different receptors,
depending on the cell type. HSV-1’s envelope has several surface glycoproteins that are required
for viral entry into host cells. The glycoproteins gB, gC, gD, gH and gL are primarily responsible
for attachment to cellular receptors and fusion of membranes (Pertel et. al., 2001). The interaction
between gB/gC surface proteoglycans and heparan-sulphate moieties on the host cell facilitates
attachment of virus particles. gB interacts and binds with the paired immunoglobulin-like type 2
receptor-alpha (PILR-alpha). Similarly, gD binds to herpes virus entry mediators (HVEMs)
(Campadelli‐Fiume et. al., 2000). These HVEMs include nectin-1, nectin-2 or 3-Osulphotransferase-modified heparan sulphate. Binding of both gB and gD to their host cell
counterparts initiates viral fusion with the membrane. Fusion events are further mediated by gB
and the gH–gL heterodimer, which ultimately results in the release of the viral nucleocapsid into
4

the cytoplasm of the host cell (Figure 2). The nucleocapsid is then transported to the nuclear
membrane by utilizing the cell’s microtubule network. The viral DNA then enters the nucleus.
Once the viral DNA has breached the host cell nucleus, transcription of viral genes commences
and the process of creating new virus particles begins (Sodeik et. al.,1997; Campadelli‐Fiume et.
al., 2000).

Figure 2: HSV-1 attachment and entry into a host cell membrane. gB/gC bind heparan-sulphate
moieties on the host cell facilitates attachment of virus particles. gB interacts and binds with the
PILR-alpha. gD binds HVEMs including nectin and initiates viral fusion with the membrane.
Fusion events are further mediated by gB and the gH–gL heterodimer, which ultimately results in
the release of the viral nucleocapsid into the cytoplasm of the host cell (Reproduced from
Manservigi et. al., 2010).
Ligand binding to HVEM activates nuclear factor kappa B (NF-κB) and stimulates T cells.
However, binding of HSV-1’s glycoprotein gD inhibits these events and is one example of how
HSV-1 alters normal immune strategies (La et. al., 2002). It is in this way that HSV produces many
proteins that contribute to immune evasion. Infected-cell protein null (ICP0) is a viral protein
5

secreted during the early stage of infection and is responsible for viral replication and reactivation
of latent herpes virus. ICP0 is associated with a decrease in IFN-γ production and is believed to
stimulate the degradation of cellular proteins through the proteasome (Lin et. al., 2004; Boutell
and Everett, 2003).

Additionally, ICP47 binds to the transporter associated with antigen

processing 1/2 (TAP1/2) and blocks HSV peptide presentation by the major histocompatibility
complex I (MHC class I) (Bauer and Tampe, 2002).
Macrophages
Macrophages are specialized cells of the innate immune system that are derived from
monocytes found in the circulatory system. Macrophages are capable of killing extracellular
pathogens that enter the blood, and help to clear tissue debris by phagocytosis. These cells also
play a role in repairing damaged tissue (Mills, 2012). To combat intracellular pathogens,
macrophages activate T and B cells through the production of multiple cytokines (Small et. al.,
1994). When T lymphocytes are stimulated by a microbe, they release cytokines that encourage
their differentiation into T helper 1 (Th1) cells and T helper 2 (Th2) cells. These helper cells
mediate the functions of effector cells, which is crucial for host defense (Mosmann et. al., 1986).
M1 vs. M2 Macrophage Polarization
M1 and M2 macrophages phenotypes are converted from a naïve state upon specific
stimuli. Under special conditions (i.e., during infection), Th1 cells, NK cells, and macrophages
produce IFN-γ that induces the classically activated M1-macrophage phenotype (Dale et. al. 2008).
The addition of IFN-γ and LPS to the J774A.1 macrophage cell line induces the M1 state that
appears as irregularly flattened cells with visible intracellular vacuoles (Reichard, 2012). M1 cells
secrete large amounts of pro-inflammatory cytokines such as IL-1B, IL-6, IL-23, TNF, iNOS, and
6

IL-12 and are bactericidal. In addition, they release chemokines and display increased levels of
MHC molecules responsible for presenting antigens to the rest of the immune system (Martinez
and Gordon, 2014; Ding et. al., 1988). The M1 macrophage response is necessary to control viral
replication; however, the inflammation that ensues can cause substantial host tissue damage (Ding
et. al., 1988).
In contrast with the M1 state, the alternatively activated M2 macrophage exhibits antiinflammatory functions, tissue damage repair, and induces angiogenesis (Novak and Koh, 2013).
M2 has more than three subclasses based on gene expression profiles, M2a, M2b, and M2c. M2 is
activated by IL-4 produced from Th2 cells, macrophages themselves, eosinophils, and basophils
(Martinez and Gordon, 2014). Additionally, IL-13, IL-1R, and IL-10 from Th2 and leukocytes
induce M2a, M2b, and M2c subclasses, respectively. IL-10 and TGF-β, two anti-inflammatory
mediators, are produced by M2 macrophages (Mantovani et. al., 2004) (Table 1). IL-4 knockout
mice display susceptibility to parasites such as, Cryptococcus neoformans, demonstrating the
significance of M2 macrophages in host protection (Martinez et. al., 2009).
During inflammation, M1 and M2 macrophages display plasticity by being able to
transition from one phenotype to the other continuously in order to achieve optimal macrophage
function and homeostasis (Stout et. al., 2005, Davis et. al., 2013). An imbalance between M1 and
M2 phenotypes is related to neurodegenerative diseases including Parkinson's disease (Tang and
Le, 2015).
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Table 1: Phenotypes of M1 and M2 macrophage subsets and their functions. M1 and M2 polarized
macrophages show different opposing activities, origin, and molecular basis (Adapted from Hao et.
al., 2012 and Duluc et. al., 2007).

Stimulation

Macrophage polarization
M2 program
M1 program
M2a
M2b
IFN-γ and LPS
IL4/IL13
LTR/IL-1R

Expression

CD86, CD80,
MHC II ↑, and
iNOS

CD163, MHC
II,

Cytokines
Produced by
macrophage
sub-sets

TNF- α
IL-1-β
IL-6, IL-12
IL-23

IL-10, TGF- β,
and IL-1ra

CD86

M2c
IL-10
CD163

MHC II
IL-1, IL-6,
IL-10, and
TNF- α

IL-10 and
TGF- β

Macrophage Events during HSV Infection and Cytokine Involvement
The innate immune system responds to HSV infection within a few hours through
activation of macrophages and NK cells. Antiviral activity appears within the first 8 hours in vitro
and 12 hours in vivo (Mogensen, et. al., 1989). HSV-1 infection induces macrophages to release
galectins 1 and 3 in the extracellular space. Galectins block viral entry to the target cell by binding
to HSV-1’s membrane glycoproteins (Miettinen et. al., 2012).
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Macrophages detect the presence of HSV-1 through pattern recognition receptors (PRRs)
on their surface that bind pathogen-associated molecular patterns (PAMPs) expressed on HSV-1,
ultimately leading to macrophage stimulation (Medzhitov and Janeway, 2002). While IFN is
present prior to HSV-1 infection, or through autocrine signaling of IFN-α/β on macrophages
(Mogensen and Virelizier, 1987), macrophages infected with HSV produce high levels of IFN-α/β
and TNF cytokines. TNF-α signaling activates NF-κB, and its translocation from the cytosol into
the nucleus. Once in the nucleus, NF-κB turns on gene expression of numerous inflammatory
cytokines. IFN-α/β and TNF-α mediators activate macrophages to release reactive oxygen species
(ROS) and reduce the spread of HSV to other cells by inactivating extracellular viruses (Paludan
et. al., 1998) (Figure 3).

Figure 3: Initial macrophage responses to HSV-1 infection result in the generation (shown
in green) of IFN-α/β and TNF cytokines and ROS that serve to prevent (shown in red) the spread
of the virus to other cells (Reproduced from Ellermann-Eriksen, 2005).
9

A 2004 study by Al-Khatib et. al. delivered INF-β into the eyes of mice via an adenovirus
vector prior to infection of the eye with HSV-1. They found that the mice demonstrated reductions
in viral titer, viral gene expression, IFN-γ levels, and CD8+ T lymphocyte and NK cell infiltration.
These effects were attributed to IFN-α /β’s ability to prevent viral protein translation by inhibiting
the eukaryotic initiation factor (eIF-2α) and inducing 2′-5′-oligoadenylate synthetase (OaS1a).
OaS1a binds to the endoribonuclease RNase L that cleaves single-stranded mRNA and rRNA and
blocks protein synthesis.
IFN and TNF also induce the generation of iNOS, which creates nitric oxide and inhibits
viral replication. Conversely, IL-4 inhibits iNOS; however, TNF and IFN-γ are able to prevent
IL-4 from inhibiting iNOS formation (Figure 4).

Figure 4: The role of cytokines in the regulation of macrophage iNOS production in response to
HSV-1 infection. IFN--γ and TNF stimulate the production of iNOS, which creates nitric oxide in
order to prevent viral replication generation (shown in green). iNOS generation is inhibited by
IL-4. TNF and IFN-γ are able to overcome the effect of IL-4 (shown in red) (Reproduced from
Ellermann-Eriksen, 2005).
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INF-γ is also produced in response to HSV-1 infection. It circulates in the blood stream
and plays a role in both innate and adaptive immunity. It activates different types of cells through
specific receptors and helps to protect the cells from HSV-1 and other viral infections. INF-γ
activates Janus kinase (JAK), thereby mediating signal transducer and activator of transcription
(STAT)1 activation, converting M0 macrophages to M1 and inducing the secretion of proinflammatory cytokines (Zhou et. al., 2014) (Figure 5).

Figure 5: Interferon-mediated M1 polarization through the JAK/STAT pathway. INF-α, β, or γ
bind to their receptor on the macrophage surface; this leads to the activation of the receptor and
phosphorylation of JAK. JAK phosphorylates STAT-1 and phosphorylated STAT-1 dimerizes and
the STAT complex translocates to the nucleus. STAT then activates the expression of genes
involved in converting M0 macrophages to M1 and inducing the secretion of pro-inflammatory
cytokines. SOCS3 inhibits STAT-1 activation, ultimately blocking the conversion of M0 to M1
macrophage phenotypes (Reproduced from Zhou et. al., 2014).
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Cluster of Differentiation (CD) markers
In addition to displaying separate phenotypes, M1 and M2 have different functions, gene
expression, and cell surface markers (Mantovani et. al., 2004). M1 and M2 macrophages can be
distinguished by using different cluster of differentiation (CD) markers antibodies, CD80, CD163,
and CD200R. The anti-inflammatory M2 cells display scavenger, mannose, and galactose-type
receptors (Peiser and Gordon, 2001). CD80 is specific to human M1 polarized macrophages and
CD200R is a specific marker to polarized human M2 (Jaguin et. al., 2013).
CD80, or B7-1, is a co-stimulatory signal that is involved in initiation and maintenance
of T cells. It is expressed on the surface of antigen presenting cells, activated B cells, and
monocytes. CD80/CD86 can bind to their cognate receptor, CD28 or cytotoxic T-lymphocyteassociated protein 4 (CTLA4), resulting in initiation or inhibition of naive T-cell activation
(Linsley et. al., 1991; Walunas et. al., 1996, respectively). A previous study performed in J774A.1
cells showed that CD86 expression was up regulated in uninfected M1 polarized macrophages
compared to uninfected M2 polarized cells. In contrast, CD86 expression reduced in M1, M2, and
control macrophages infected with HSV-1 (Reichard, 2012).
CD163 is a glycoprotein of the scavenger receptor cysteine-rich (SRCR) superfamily type
B (Law et. al., 1993; Kristiansen et. al., 2001). It is a marker for anti-inflammatory activities in
monocyte/macrophage cell populations. CD163 is the endocytic receptor binding hemoglobin
complexed with the plasma protein haptoglobin: it is produced during the early response to host
injury. CD163 on the surface of the macrophage binds to either hemoglobin or heme when present
at high levels. CD163 expression is enhanced by stimulation of monocyte/macrophage cells with
IL-6, IL-10, and glucocorticoids and is not affected by IL-4 or IL-13 (Koning et. al., 2010),
whereas LPS, INF-γ, and TNF-α reduce its expression (Buechler et. al., 2000; Högger, et. al.,
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1998). CD163 was classified as a marker of M2C cells. It was recently found that CD163 also
exists as a soluble form in plasma (sCD163): this form is induced by LPS and other stimuli
(Sulahian et. al., 2001). The majority of sCD163 is expressed in patients with myelo-monocytic
leukemia and infection (Møller et. al., 2002). In this study, CD163 was selected to distinguish
among macrophage populations and was used as a marker for the M2 phenotype.
The CD200 receptor (CD200R) is a membrane glycoprotein that acts as an immuneinhibitory receptor thereby preventing inflammatory macrophage activation (Hoek et. al., 2000).
CD200R is displayed predominantly on myeloid cells, monocyte/macrophages, dendritic cells, and
on a subgroup of activated T and B cells. CD200R binds CD200, which is a type 1 membrane
glycoprotein of the Ig superfamily and is expressed in several cell types (Rijkers et. al., 2008).
CD200R on M2 cells, specifically M2a, induces an anti-inflammatory response that limits
potentially damaging pro-inflammatory responses, in part by reducing the production of proinflammatory cytokines (Jenmalm et. al., 2006).
INF-γ can stimulate expression of CD200R in murine macrophages, unlike human
macrophages where it is unable to do so. When human cells were stimulated with IL-4 for 3 days
in vitro, their expression of CD200R expression increased (Koning et. al., 2010). In this study, we
investigate the effect of HSV-1 infection on CD200R expression on murine macrophages.
Suppressor of Cytokine Signaling Proteins
Suppressor of cytokine signaling (SOCS) proteins negatively regulate cytokine receptor
signaling and TLR. There are eight types of SOCS proteins currently identified: CIS and SOCS1
- SOCS7. All SOCS proteins consist of a ~50 amino acid carboxy-terminal SOCS box and an Src
homology 2 (SH2) domain. The SH2 domain of SOCS proteins interact with phosphotyrosine
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phosphorylated proteins. The SOCS box domain interacts with the elongin BC complex, which
inhibits the SOCS proteins degradation (Yoshimura, 2005).
SOCS1 and SOCS3 can be induced by cytokines (such as IFN-γ) or TLR ligands (through
LPS). When one of these cytokines binds to its receptor, JAK1 and JAK2 are phosphorylated and
the receptor becomes activated. STAT binds to the activated receptor and is activated by
phosphorylation. Upon dissociation from the receptor, phosphorylated STAT dimerizes and the
STAT complex translocates to the nucleus. STAT then binds to the genes for SOCS1 and SOCS3,
as well as other cytokine-induced genes leading to expression (Hu et. al., 2002; Alexander, 2002)
(Figure 6A).
SOCS1 and SOCS3 inhibit JAK activity
SOCS1 and SOCS3 proteins also have a kinase inhibitory region (KIR) near the aminoterminal domain (Figure 6B) that eliminates JAK activity. SOCS1 binds directly to JAK,
preventing its catalytic activity. Conversely, SOCS3 binds to areas of cytokine receptors adjacent
to JAK’s binding location, inhibiting JAK activity through the KIR. Both the SOCS1 and SOCS3
complexes can then be targeted for degradation by ubiquitination recruited through the SOCS box.
Therefore, SOCS molecules tightly control the duration and intensity of cytokine actions by JAKSTAT signaling (Yoshimura, 2005; Yoshimura and Yasukaw, 2012). Furthermore, SOCS3
regulates STAT3 signaling and therefore controls whether STAT3 leads to pro-inflammatory or
anti-inflammatory signals. Ultimately, increases in SOCS3 lead to anti-inflammatory signals.
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Figure 6: Activation of JAK–STAT signaling through cytokines binding its receptor. A) Cytokines
induce JAK activity. B) SOCS proteins inhibit JAK activity (Reproduced from Alexander, 2002;
Shuai and Liu, 2003)
SOCS1 and SOCS3 also play roles in macrophage polarization by regulating NF-κB,
phosphoinositide 3-kinases (PI3Ks), and extracellular signal-regulated kinase (ERK) signaling
pathways. Specifically, SOCS3 inhibits cytokine-induced activation of SMAD3, STAT3, STAT6,
and PI3K, thereby inhibiting macrophage polarization to the M2 state. Conversely, SOCS1 inhibits
STAT1 and NF-kB activity induced by cytokines, preventing M1 polarization (Wilson, 2014).
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MATERIALS AND METHODS

HSV-1 and Cell Lines
HSV-1 (syn17+) (courtesy of Dr. Nancy Sawtell, Children’s Hospital Medical Center,
Cincinnati, OH) was titrated in Vero cells (CCL-81). J774A.1 and RAW 264.7 are murine
macrophage-like cells. J774A.1 is a reticulum cell sarcoma, an adherent macrophage cell line
derived from an adult female BALB/cN mouse. RAW 264.7 is Abelson murine leukemia virusinduced tumor derived from an adult male BALB/C mice. All cell lines were purchased from
American Type Culture Collection (ATCC, Manassas, VA). J774A.1 cells were maintained in a
medium consisting of Dulbecco's Modified Eagle's Medium (DMEM, HyClone) supplemented
with 10% Fetal Bovine Serum (FBS; Fisher Scientific) and 1% antibiotic antimycotic solution
(10000 U/mL penicillin, 10000 μg/mL streptomycin, and 25 μg/ml Ampholericin B) PSG (1%
penicillin-streptomycin and 0.1% gentamycin, each at 10000U/mL) in a humidified 5%
CO2 incubator at 37ºC. J774A.1 cells were cultured in 100 mm x 20 mm cell culture treated Petri
dishes (BD Biosciences). Cultures were split 1:5 every other day.
Polarization Induction
When J774A.1 macrophages reached approximately 50-70% confluency (by observation),
culture medium was replenished with IFN-γ and LPS supplemented media. A final concentration
of 20 ng/ml IFN-γ (Peprotech)/ 100 ng/mL LPS (Chondrex) was used to induce the M1 phenotype.
The M2 phenotype was induced with 20 ng/ml of either IL-4 or IL-13, or IL-10 at 10 ng/ml
(Peprotech). Cultures were allowed to polarize for 18, 24, or 48 hours. Cells were collected from
the culture dishes using a cell scraper to analyze cell viability, morphological changes, and CD
markers by flow cytometry and immunofluorescence.
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Cell Viability
J774A.1 macrophages were grown to approximately 70% confluency (by observation), at
which time either IFN-γ/LPS (M1) or IL-4, IL-10, or IL-13 (M2) was added with or without
infection at a multiplicity of infection (MOI) of 0.1 HSV-1 per cell. Untreated cells were used as
a control. After 18, 24, and 48 hours, cells were collected from the 24-well plates using a cell
scraper. The supernatant was aspirated after centrifugation (1500 rpm for 5 minutes, at 4°C). The
cell pellet was suspended in 1 mL of 10% DMEM medium. The cells were stained with trypan
blue (Fisher Scientific) to determine cell viability using a haemocytometer using the following
equation.
% Cell Viability = [Total Viable cells (Unstained) / Total cells (Viable +Dead)] X 100.

Immunofluorescence Staining
J774A.1 macrophages were plated and grown on sterile glass coverslips (Fisher Scientific)
at 3 × 105 cells per well of a 6-well plate. Once the coverslips reached approximately 50%
confluency, the cells were stimulated with IFN-γ/LPS or IL-4, IL-10, or IL-13, with or without
HSV-1 (MOI of 0.1). Following incubation for 18, 24, or 48 hours, culture media was aspirated
and cells were washed with 1% bovine serum albumin (BSA) suspended in phosphate buffered
saline (PBS). Cells were fixed with 4% paraformaldehyde in PBS for 15 minutes at room
temperature. Cells were then rinsed three times with 1% BSA in PBS for three minutes each. Cells
were blocked for non-specific binding with 3% BSA in PBS and incubated for one hour at room
temperature. Cells were then rinsed three times with 1% BSA in PBS for three minutes each.
Diluted primary antibodies (Table 2) in the blocking buffer (3% BSA in PBS) were applied directly
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onto the cells and incubated overnight at 4°C. Cells were then rinsed three times with 1% BSA in
PBS for three minutes each. Stained cells on coverslip were mounted with drop of Vectashield
hard-set mounting medium (H-1400, Vector Laboratories) onto microscope slides and visualized
on an Olympus Epi-fluorescence microscop equipped with a “spot” digital camera.
Table 2: Summary of Primary Antibody Concentrations used to show CD makers
expression on the un-polarized and polarized macrophages for Immunofluorescent staining.

Antibody
Texas Red-Phalloidin X

Concentration/Dilution
(3μg/million cells)

Company
Life Technologies

Anti-CD80 antibody
conjugated to Pacific blue
Anti-CD163 antibody
conjugated to FITC

(2μg/million cells)

Biolegend

(2μg/million cells)

Antibodies-Online Inc.

(2μg/million cells)

Antibodies-Online Inc

Anti-CD200R antibody
conjugated to Alexa Fluor 488
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Flow Cytometric Analysis
J774A.1 macrophages were plated on 150 mm x 15 mm petri dishes (BD Biosciences) and
incubated until 50% confluent. The following day, cells were treated with either IFN-γ/LPS, IL-4,
IL-10, or IL-13 with or without HSV-1 for 24 hours. Cells were collected using a cell scraper and
viability was calculated with a hemocytometer using the trypan blue exclusion test.
Cells were washed three times with 1% BSA in PBS. Cells were blocked for non-specific binding
with 3% BSA in PBS and incubated for one hour at room temperature. Cells were then rinsed three
times with 1% BSA in PBS. The cells were incubated (light-protected) with the primary antibodies
(Table 3) and isotype control antibodies for respective antibodies diluted in the blocking buffer
(3% BSA in PBS) for 1 hour at 4°C and washed three times with 1% BSA in PBS. The cell pellet
was then re-suspended with ice cold PBS with 0.5% sodium azide buffer and analyzed by the
Accuri C6 flow cytometer.
Table 3: Summary of Primary Antibody Concentrations used to show CD makers
expression on the un-polarized and polarized macrophages for flow cytometry.

Antibody

Concentration/Dilution

Company

Anti-mouse CD80
conjugated to PE/Cy5

(2μg/million cells)

Biolegend

Anti-CD163 conjugated to
FITC

(2μg/million cells)

Antibodies-Online Inc.

Anti-CD200R conjugated
to FITC

(2μg/million cells)

Biolegend
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SOCS Experiments
Twenty-four hours prior to treatment, J774A.1 macrophages were grown, in triplicate, in
24-well plates at a density of 5 × 104 cells per well. The culture medium was then replaced by fresh
DMEM containing 10% FBS and treated with 20 ng/ml IFN-γ and LPS (100 ng/mL) to convert
the cells to the M1 phenotype. SOCS1 peptide (35μM/ml), SOCS3 peptide (35μM/ml) or PJAK2
(SOCS1 inhibitor, 35μM/ml) was added to the cells, with or without HSV-1 (MOI of 0.1). The
cells were incubated for 24 hours.
In a separate experiment, SOCS3 peptide (35μM/ml) or tissue culture medium was added
to the cell culture for 30 minutes. The cells were either infected with HSV-1 (MOI of 0.1) for 24
hours or induced to an M1 state using 20 ng/ml IFN-γ and LPS (100 ng/mL), or both.
After incubation cells were collected from the 24-well plates using a cell scraper and
centrifuged at 1500 rpm for 5 minutes. The supernatants were collected and stored at −80°C for
subsequent IL-1β, IL-6, TNF-α, and IL-10 measurements. The cell pellet was re-suspended in 1
mL of 10% DMEM medium. The cells were stained with trypan blue to determine cell viability.
Cytokine Measurements
The frozen supernatants were evaluated for IL-1β, IL-6, TNF-α or IL-10 concentrations
using Luminex Multiplex Immunoassays (R&D Systems) in accordance with manufacturer’s
instructions.
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Statistical Analysis
All experiments were carried out at least three times. Flow cytometry and cell viability data
shown were from representative experiments. The statistical significance of differences between
testing and control experimental groups was analyzed by one way ANOVA using Sigma Plot 12.0
software. P values equal to or less than 0.05 were considered to be statistically significant, and
data are represented as the mean ± standard error of the mean.
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RESULTS
Uninfected and Infected with HSV-1 Control and Cytokines Polarized Macrophages
Polarization of J774 Macrophage Cells Line Alter Morphology
Macrophages were treated for 18, 24, or 48 hours with IFN-γ and LPS to induce the M1
phenotype or with IL-4, IL-10, or IL-13 to induce the M2 phenotype. Morphological examination
showed that the polarized macrophages exhibited different morphologies with and without HSV1 (MOI 0.1).
Uninfected M1 macrophages appeared as flattened, extended irregular shapes, contained
visible intracellular vacuoles, and attached to the plates (adherent), whereas M0 and M2 cells
displayed a rounded cell shape at 18 (Figure 7), 24 (Figure 8), and 48 hours (Figure 9), with some
M2 macrophages appearing elongated. At 24 and 48 hours, M1 macrophages demonstrated the
same morphological changes described above for 18 hours, although the irregular shape and
intracellular vacuoles were more pronounced (Figure B in 8 & 9).
HSV-1 Infection of Polarized Macrophages Further Alters Morphology
M0, M1 and M2 macrophages became rounded following infection with HSV-1 (MOI 0.1)
for 18, 24, and 48 hours (Figure 10, 11, &12 from A-E). Infected M1 macrophages showed
different morphological changes compared with uninfected M1 macrophages. Uninfected M1 cells
were flattened, displayed extended irregular shapes, and had intracellular vacuoles (Figure B in 7,
8, & 9); however, HSV-1 infected M1 macrophages were rounded (Figure B in 10, 11, &12).
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Cell Viabilities of Unpolarized of Polarized Macrophages after 18, 24, and 48 Hours With
and Without HSV-1 Infection
J774A.1 macrophages were treated with IFN-γ/LPS (M1) or IL-4, IL-10, or IL-13 (M2)
with or without HSV-1 (MOI 0.1) for 18, 24, and 48 hours. The cells were stained with trypan
blue to determine the number of live versus dead cells. Cell viabilities for M1 and M2 macrophages
were compared with those of untreated M0 cells as the control.
Polarization of J774A.1 macrophages for 18 hours leads to a statistically significant
decrease in cell viability in M1 (25% p <0.001) and M2 macrophages induced by IL-4 (13%, p
<0.05), but the decrease was not significant for M2 subgroups induced by IL-10 (~11%) or IL13(3%) or compared to M0 control cells (95% )(Figure 13A). At 24 hours following polarization,
M1 macrophages (18%, p <0.001) displayed a reduction in cell viability whereas both IL-4 and
IL-10-induced M2 macrophages also showed significant, although minor, decreases in viability
(~13%, p <0.05) compared to M0 control cells. There was no significant difference in cell viability
between IL-13-induced M2 macrophages (3%) and M0 control cells (~97%) (Figure 14A). Cell
viability for M1 macrophages at 48 hours post-polarization was similar to that observed after 24
hours (~21%, p <0.001). M2 macrophages, regardless of method of induction, demonstrated
minor, not statistically significant reductions in viability compared with M0 macrophage (Figure
15 A). The cell viability was significantly lower in uninfected M1 macrophages (77%) compared
to uninfected M2 macrophages polarized by IL-4 (8%, p< 0.05), IL-10 (11%, p=0.001), and IL-13
(9%, p<0.01) (Figure 15 A).
At 18 hours following polarization and HSV-1 infection, M1 infected macrophages (21%,
p <0.001) exhibited a significant decrease in cell viability compared to infected M0 control cells
(85%); M2 infected macrophage induced by IL-4, IL-10, and IL-13 did not display a significant
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reduction (Figure 13 B). Compared to infected M0 cells (~88%), a significant decrease in cell
viability was seen in M1 infected macrophages cells (~21%, p <0.05) (Figure 14 B). HSV-infected
M2 macrophages activated by IL-4, or IL-13(~2%) did not show significant differences in cell
viability compared to HSV-infected M0 control cells. HSV-infected M2 macrophages polarized
by IL-10 (10%) exhibited a reduction in cell viability, although this reduction was not significant
(Figure 14 B). The cell viability was significantly lower in infected M1 macrophages compared to
M2 infected macrophages induced by IL-4 or IL-13 (19%, p =0.05 or ~21%, p <0.001,
respectively) at 24 hours (Figure 14 B). Compared to the viability of infected M0 cells (80%) at
48 hours, decreases in cell viability were observed in infected M1 macrophages (18%, p <0.005)
and infected M2 macrophages activated by IL-4 (18%,p <0.001), IL-10 (14, p <0.005), and IL-13
(20%, p <0.001) (Figure 15B).
CD Marker Expression of polarized and control macrophages before and after HSV-1
infection
CD marker expression by un-polarized and polarized macrophages following 18, 24, and
48 hours of cytokine treatment in the presence and absence of HSV-1 infection was evaluated.
Immunofluorescence staining with flow cytometry was performed at 18, 24, or 48 hours. CD80
expression on uninfected M1 macrophages was the highest at 18 and 24 hours, whereas it
decreased at 48 hours. There were no apparent differences in the CD80 expression between these
macrophages at different points in time (Supplemental figure 1). Infected M1 macrophages
displayed an increase in CD80 expression at 24 and 48 hours (Supplemental figure 2).
M2 macrophages induced by IL-10 or IL-13 showed higher expression of CD163 at 24
(M2/IL-10) and 18 hours (M2/IL-13). CD163 expression was down-regulated among
macrophages (Supplemental figure 3). Infected M2 macrophages polarized by IL-10 or IL-4
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showed an up-regulation of CD163 expression at 24 and 48 hours. CD163 expression was downregulated among macrophages (Supplemental figure 4).
Uninfected M2 macrophages polarized by IL-4 showed an up-regulation of CD200R
expression at 18 and 24 hours. No difference in CD200R expression were observed among
macrophages (Supplemental figure 5). CD200R expression was highly up-regulated in infected
M2 macrophages induced by IL-13 at 24 hours, and slightly high in infected M2 macrophages
induced by IL-4 and IL-13 at 24 hours (Supplemental figure 6).
CD80: Flow cytometry was used to evaluate CD marker expression for control and
polarized macrophages following 24 hours of cytokine treatment with or without HSV-1 infection.
CD80 expression was insignificantly reduced on uninfected M1 macrophages (49%), M2
macrophages activated by IL-4 (45%), IL-10 (55%), and IL-13 (51%) compared to uninfected M0
macrophages (63%) (Figure 16 A&B). Following HSV-1 infection for 24 hours, M1 macrophages
and M2 macrophages stimulated by IL-10 exhibited a minor increase in CD80 expression (56%
and 57%, respectively) compared to infected M0 macrophages (53%) while M2 macrophages
stimulated by IL-4 and IL-13 displayed slightly decreased levels of CD80 (51%) (Figures 17 A &
B). In comparison to uninfected CD80+ M1 macrophages (49% of the population) and CD80+ M2
macrophages stimulated by IL-4 (45% of the population) or IL-10 (55% of the population), CD80
expression was slightly up-regulated in infected M1 macrophages (56% of the population) and M2
macrophages stimulated by IL-4 or IL-10 (51% and 57% of the population, respectively) (Figure
18). There was no change in CD80 expression in M2 macrophages stimulated by IL-13 before
and after HSV-1 infection (Figure 18). The CD80 expression results were not statistically
significant.
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CD 163: The level of CD 163 expression was similar in both uninfected M0 and M2
macrophages induced by IL-10 (31% of the population) (Figures 19 A and B). The slight decrease
in CD 163 expression on uninfected M1 and M2 macrophages induced by IL-4 or IL-13 was not
statistically significant (Figures 19 A and B). Infected M2 macrophages induced by IL-10 (34%
of the population) showed a minor increase in CD163 expression compared to infected M0 control
(29% of the population). CD163-expressing infected M1 macrophages (21% of the population)
and infected M2 macrophages induced by IL-4 or IL-13 (~26% of the population for both) were
slightly decreased compared to CD163-expressing infected M0 control macrophages (29% of the
population) (Figures 20 A and B). Uninfected and HSV-infected M0, M1 and M2 macrophages,
regardless of manner of induction, exhibted slightly variable levels of expression of CD163, with
CD163+ macrophages represented 20-30% of the population in all conditions (Figure 21). There
were no statistically significant differences among any of the macrophage phenotypes regardless
of infectious state.
CD200R: CD200R was expressed on 28% of the population of uninfected M0
macrophages (Figures 22 A & B). CD200R expression was similar in uninfected M2 macrophages
induced by IL-4 (25% of the population) or IL-10 (26% of the population). Uninfected M1
macrophages showed reduced CD200R expression (19% of the population) and only 20% of the
population of M2 macrophages induced by IL-13 were CD200R+ (Figures 22 A & B).
The CD200R expression slightly increased in infected M1 macrophages (21% of the
population), and infected M2 macrophages induced by IL-4 (24% of the population), IL-10 (26%
of the population), and IL-13 (27% of the population; p< 0.05) compared to infected M0
macrophages (Figures 23 A & B). There was an insignificant decrease in the number of CD200R+
HSV-1 infected M0 macrophages (17% of the population) compared to uninfected M0
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macrophages (28% of the population) (Figures 24). However, there was no significant change in
CD200R expression in M1 and M2 macrophages stimulated by IL-4 and IL-10 pre- and post-HSV1 infection (Figure 24). The number of CD200R+ in infected M2 macrophages stimulated by IL13 (27% of the population) was greater than uninfected M2 macrophages stimulated by IL-13
(20% of the population) (Figure 24): these results were not statistically significant. These data are
summarized in (Table 4).

Effects Of SOCS1, SOCS3 Peptide Mimetics, and pJAK2 (SOCS1 Inhibitor) on Cell
Viabilities of Polarized M1 J774A.1 Macrophages and RAW 264.7 macrophages

Cell viabilities of polarized M1 and HSV-1-infected M1 J774A.1 macrophages were
determined following treatment with SOCS1 and SOCS3 peptide mimetics and pJAK2 for 24
hours. The SOCS3 peptide mimetic and pJAK2 resulted in increased viability of polarized M1
macrophages compared with SOCS1 treated cells (p<0.001). There was no difference between
infected and uninfected groups (Figure 25). J774A.1 M1 cells produce high levels of TNF-α and
IL-6 compared to M1 cells treated with either SOCS3 peptide mimetics or pJAK2 (Table 5). M1
cells treated with SOCS3 behave similar to the M2 phenotype and produce the anti-inflammatory
cytokine IL-10 (Table 5). The polarized M1 macrophage viability decreased in response to the
SOCS1 peptide mimetic (p<0,001), with no significant difference observed between virus and nonvirus infected cells (Figure 25).
The effect of the SOCS3 peptide mimetic was tested to examine its ability to modify the
cytotoxic effects of M1 polarization or HSV-1 infection. RAW 264.7 macrophages were treated
with SOCS3 and then were either infected with HSV-1, polarized by M1, or both. When compared
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with the untreated controls (~65%), the SOCS3 peptide mimetic increased cell viability in the M1
(~78%) and HSV-1 + M1 group (~83%) (p< 0.05) (Figure 26). However, SOCS3 did not
significantly affect HSV-1 only treated cells (Figure 26). Pro- inflammatory cytokines, IL-6 and
TNF-α were increased in M1 cells compared to M1 treated with SOCS3 and M2 macrophages
induced by IL-4, IL-10, or IL-13. However, IL-1β treatment did not show a change between M1,
M1 treated with SOCS3, and M2 macrophages. A decrease in IL-10 production was seen in M1
cells, while M1 cells treated with SOCS3 and IL-4 or IL-13 polarized M2 macrophages increased
the production of IL-10. IL-10 polarized M2 macrophages show high levels of IL-10 because IL10 is both an inducer and an effector molecule in these cells (Figure 27). It appeared that the
SOCS3 peptide mimetic protected RAW 264.7 macrophages from the lytic effects of M1
polarization and SOCS3 causes M1 macrophages to behave similar to the M2 phenotype. The same
experiments were performed in the J774 cell line. The SOCS3 peptide mimetic showed no
significant effect on HSV-1 infected, M1 polarized, or HSV-1 + M1-treated J774 cells; however,
the SOCS3 peptide mimetic increased cell viability in HSV-1-infected M1 J774A.1 macrophages
(Figure 28). This result suggests that SOC3 mimetic exerts an anti-inflammatory effect by
diminishing the lytic effect of M1 polarization.
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Figure 7: Changes in Cellular Morphology of Polarized and Un-polarized J774A.1 Macrophages
18 hours pre- HSV-1 infection. A-E show unpolarized and cytokine-stimulated (polarized)
macrophages that were fixed and stained with phalloidin (for filamentous actin arrangement), and
then evaluated by immunofluorescence microscopy. A shows unpolarized control (M0), B, M1
macrophages polarized by LPS and IFN-γ, and C- F shows M2 macrophages polarized by IL-4,
IL-10, and IL-13 respectively. M1 macrophages were elongated, and begin to form intracellular
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vacuoles in the cytoplasm. M2 macrophages induced by IL-4, IL-10, and IL-13 were rounded and
displayed no changes in morphology as compared to control macrophages. (Scale bar =50μm).
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Figure 8: Changes in Cellular Morphology of Polarized and Un-polarized J774A.1 Macrophages
24 hours pre- HSV-1 infection. A-E show unpolarized and cytokine-stimulated (polarized)
macrophages that were fixed and stained with phalloidin (for filamentous actin arrangement), and
then evaluated by immunofluorescence microscopy. A shows unpolarized control (M0), B, M1
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macrophages polarized by LPS and IFN-γ, and C- F shows M2 macrophages polarized by IL-4,
IL-10, and IL-13 respectively. M1 macrophages displayed irregular shapes and intracellular
vacuoles were more pronounced than 18 hours. M0 appeared rounded or elongated, and M2
macrophages induced by IL-4 and IL-13 show elongation with the majority of cells appearing
rounded. M2 macrophages induced by IL-10 were rounded. (Scale bar =50μm).
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Figure 9: Changes in Cellular Morphology of Polarized and Un-polarized J774A.1 Macrophage
48 hours pre- HSV-1 infection. A-E showed un-polarized and cytokine-stimulated (polarized)
macrophages were fixed and stained with phalloidin (for actin arrangement), and then evaluated
by immunofluorescence microscopy. A showed un-polarized control (M0), B, polarized M1
macrophages by LPS and IFN-γ, and C- F showed polarized M2 macrophages by IL-4, IL-10, and
IL-13 respectively. M1 macrophages exhibited the same morphological changes described at 18
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and 24 hours. M2 macrophages induced by IL-4 were elongated and rounded compared to M2
macrophages induced by IL-10 or IL-13 and M0 macrophages. (Scale bar =50μm).
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Figure 10: Changes in Cellular Morphology of Polarized and Un-polarized J774A.1 Macrophage
18 hours post- HSV-1 infection. A-E showed HSV-1 infected un-polarized and cytokinestimulated (polarized) macrophages were fixed and stained with phalloidin (for actin
arrangement), and then evaluated by immunofluorescence microscopy. A showed infected unpolarized control (M0), B, infected polarized M1 macrophages by LPS and IFN-γ, and C- F
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showed infected polarized M2 macrophages by IL-4, IL-10, and IL-13 respectively. All infected
macrophage phenotypes were rounded and aggregated. (Scale bar =50μm).
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Figure 11: Changes in Cellular Morphology of Polarized and Un-polarized J774A.1 Macrophage
24 hours post- HSV-1 infection.

A-E showed HSV-1 infected un-polarized and cytokine-

stimulated (polarized) macrophages were fixed and stained with phalloidin (for actin
arrangement), and then evaluated by immunofluorescence microscopy. A showed infected unpolarized control (M0), B, infected polarized M1 macrophages by LPS and IFN-γ, and C- F
showed infected polarized M2 macrophages by IL-4, IL-10, and IL-13 respectively. Infected
macrophages were rounded and aggregated. (Scale bar =50μm).
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Figure 12: Changes in Cellular Morphology of Polarized and Un-polarized J774A.1 Macrophage
48 hours post- HSV-1 infection. A-E showed HSV-1 infected un-polarized and cytokinestimulated (polarized) macrophages were fixed and stained with phalloidin (for actin
arrangement), and then evaluated by immunofluorescence microscopy. A showed infected un37

polarized control (M0), B, infected polarized M1 macrophages by LPS and IFN-γ, and C- F
showed infected polarized M2 macrophages by IL-4, IL-10, and IL-13 respectively. Following
HSV-1 infection, all phenotypes became rounded and aggregated. (Scale bar =50μm).

38

Figure 13: Cell viability of unpolarized (M0) and polarized macrophages (M1, M2) after 18 hours
without HSV-1 infection (A) or with HSV-1 infection (B). Percentages of viable cells are shown
as the mean and error bars represent standard error. These data represent the mean of three
independent experiments. *, p <0.05; ***, p <0.001.
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Figure 14: Cell viability of unpolarized (M0) and polarized macrophages (M1, M2) after 24 hours
without HSV-1 infection (A) or with HSV-1 infection (B). Percentages of viable cells are shown
as the mean and error bars represent standard error error. These data represent the mean of three
independent experiments. *, p ≤0.05;***, p ≤0.001.
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Figure 15: Cell viability of unpolarized (M0) and polarized macrophages (M1, M2) after 48 hours
without HSV-1 infection (A) or with HSV-1 infection (B).Percentages of viable cells are shown
as the mean and error bars represent standard error. These data represent the mean of three
independent experiments. *, p <0.05; **,p< 0.010; ***, p <0.001.
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Figure 16: Flow cytometry analysis of CD80 expression on the surface of J774.A1 murine cells.
Histograms (A) and bar charts (B) show the expression cell surface markers CD 80 for control and
polarized macrophages following 24 hours of cytokine treatment without HSV-1 infection. Red:
negative isotype control; black: PE/CY5 -conjugated anti-mouse CD80 antibodies. These results
were not statistically significant. There were no statistically significant differences between control
M0 macrophages and M1 or M2 macrophages induced by IL-4, IL-10, or IL-13.

Three

independent experiments were performed with one representative experiment shown for
histograms (A). Error bars represent standard error of three trials (B).
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Figure 17: Flow cytometry analysis of CD80 expression on the surface of J774.A1 murine cells.
Histograms (A) and bar charts (B) show the expression cell surface markers CD 80 for control and
polarized macrophages following 24 hours of cytokine treatment with HSV-1 infection. Red:
negative isotype control; black: PE/CY5 -conjugated anti-mouse CD80 antibodies. These results
were not statistically significant. Three independent experiments were performed with one
representative experiment shown for histograms (A). Error bars represent standard error of three
trials (B).
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Figure 18: CD 80 expression for control and polarized macrophages following 24 hours of
cytokines pre- and post-HSV-1 infection. These results were not a statistically significant
difference. Error bars represent standard error. Representative experiment of three trials is shown.
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Figure 19 : Flow cytometry analysis of CD 163 expression on the surface of J774.A1 murine cells.
Histograms (A) and bar charts (B) show the expression cell surface markers CD 163 for control
and polarized macrophages following 24 hours of cytokine treatment without HSV-1 infection.
Green: negative isotype control; black: FITC -conjugated anti-mouse CD 163 antibodies. There
were not a statistically significant observed, when compared M0 control to M1 and M2
macrophages induced by IL-4, IL-10, or IL-13. Three independent experiments were performed
with one representative experiment shown for histograms (A). Error bars represent standard error
of three trials (B).
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Figure 20: Flow cytometry analysis of CD 163 expression on the surface of J774.A1 murine cells.
Histograms (A) and bar charts (B) show the expression cell surface markers CD 163 for control
and polarized macrophages following 24 hours of cytokine treatment with HSV-1 infection.
Green: negative isotype control; black: FITC -conjugated anti-mouse CD 163 antibodies. These
results were not statistically significant. Three independent experiments were performed with one
representative experiment shown for histograms (A). Error bars represent standard error of three
trials (B).
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Figure 21: CD 163 expression for control and polarized macrophages following 24 hours of
cytokines pre- and post-HSV-1 infection. No statistically significant observed, when compared
M0 control to M1 and M2 macrophages induced by IL-4, IL-10, or IL-13. Error bars represent
standard error. The experiments were repeated three times.
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Figure 22: Flow cytometry analysis of CD 200R expression on the surface of J774.A1 murine
cells. Histograms (A) and bar charts (B) show the expression cell surface markers CD 200R for
control and polarized macrophages following 24 hours of cytokine treatment without HSV-1
infection.

Green: negative isotype control; black: FITC -conjugated anti-mouse CD 200R

antibodies. These results were not a statistically significant difference. Three independent
experiments were performed with one representative experiment shown for histograms (A). Error
bars represent standard error of three trials (B).
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Figure 23: Flow cytometry analysis of CD200R expression on the surface of J774.A1 murine cells.
Histograms (A) and bar charts (B) show the expression cell surface markers CD200R for control
and polarized macrophages following 24 hours of cytokine treatment with HSV-1 infection. Green:
negative isotype control; black: FITC -conjugated anti-mouse CD200R antibodies. Infected M2
induced by IL-13 (*,p<0.05) showed a statistically increase in CD200R expression level compared
to infected M0 control cells. However, other macrophages population were not statistically
significant. Three independent experiments were performed with one representative experiment
shown for histograms (A). Error bars represent standard error of three trials (B).

49

Figure 24: CD200R expression for control and polarized macrophages following 24 hours of
cytokines pre- and post-HSV-1 infection. There was a statically significant increase in infected
M2 macrophages induced by IL-13 (*,p<0.05) compared to infected M0 control cells. No
statistically significant observed, when compared M0 control to M1 and M2 macrophages induced
by IL-4 or IL-10. Error bars represent standard error. The experiments were repeated three times.
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Table 4: Summary of CD makers’ expression on the un-polarized and polarized macrophages preand post- HSV-1 infection
CD Markers
Expression

- HSV-1 or
+HSV-1

M0

M1

(63%)

NS reduced
(~45%)

-HSV-1
CD80
expression:
Unchanged

M2/IL-4

M2/IL-10

M2/IL13

NS Slightly reduced
(~55%)

(53%)

No difference (~56%)

NS
slightly
reduced

No difference

+HSV-1

HSV-1 infected
cells compared
to uninfected
CD163
expression:
Unchanged

- HSV-1

(31%)

NS slightly reduced (~22%)

+HSV-1

(29%)

NS reduced
(21%)

HSV-1 infected
cells compared
to uninfected
CD200R
expression:
changed

No difference

NS Slightly
reduced
(21%)
NS minor
reduced
(26%)

NS slightly
increased

No
difference

NS
increased

(28%)

NS Slightly
reduced
(19%)

No difference
(~26%)

NS Slightly
reduced
(20%)

(17%)

NS slightly
increased
(21%)

NS increased
(~24%)

increased
p<0.05
(27%)

-HSV-1

+HSV-1

HSV-1 infected
cells compared
to uninfected

NS minor
reduced
(26%)

No
difference
(31%)
NS minor
increased
(34%)

NS
reduced

No difference

* NS: Non Significant
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NS upregulated

Uninfected

HSV1-infected

Figure 25: Effects of SOCS1, SOCS3 Peptide Mimetics, and pJAK2 (SOCS1 Inhibitor) on cell
viabilities of polarized M1 J774A.1 macrophages. Polarized M1 macrophages are represented as
gray bars, and HSV1-infected macrophages are represented in black. ***,p<0.001.
Table 5: Comparisons ratios (pg/ml) of inflammatory cytokine produced in 2 experiments by
J774A.1 cells 24 hours after polarization.
Cytokine produced

IL-1β*

IL-6

TNF-α

IL-10

1:1

1:1

5:1

1:2

1:1

33:1

7:1

1:2

1:1

26:1

6:1

1:2

M1 vs. M1 SOCS1

M1 vs. M1 SOCS3
M1 vs. M1 pJAK2
*IFN-γ used to polarized M1 cells inhibits IL-1β expression (Eigenbrod et al. 2013
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Untreated, control cells

SOCS3 treated cells

Figure 26: Cell viabilities of RAW 264.7 macrophages 24 hours after M1 polarization. SOCS3
treated cells (black bars) were compared to the untreated, control cells (gray bars). ( *,p<0.05).
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Figure 27: Production of pro-inflammatory A) TNF-α, B) & IL-6 C) and anti-inflammatory IL-10
in 2 experiments by RAW264.7 cells 24 hours after polarization. M1 cells vs M1 cells treated with
SOCS3 mimetic vs IL-4, IL-10, and IL-13 polarized M2 cells.
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Untreated, control cells

SOCS3 treated cells

Figure 28: Cell viabilities of J774A.1 macrophages 24 hours after M1 polarization. SOCS3
treated cells (black bars) were compared to the untreated, control cells (gray bars).
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DISCUSSION

Macrophage populations are a dynamic group of cells that vary in both phenotype and
function depending on the environmental signals and stimuli. Different macrophages can be
distinguished by specific molecules expressed on their surface, e.g. CD markers, and will polarize
into M1 and M2 phenotypes upon microenvironmental stimulation. This research confirms the
findings of a previous study done by Reichard (2012) who found that J774 murine macrophages
cells exhibit diversity in cell morphology, cell viability, and cell surface proteins 24 hours
following IL-4 or IFN-γ and LPS treatment and /or HSV-1 infection. The two hypotheses around
which this research project was built are: 1) There will be differences in various macrophage
subtypes in cell morphology, viability, and surface marker expression (CD80, CD163 and
CD200R) between M1 and M2 macrophages induced by different stimuli, and 2) the SOCS3
peptide mimetic will alter the cytotoxicity associated with the M1 phenotype or HSV-1 infection.
To test cell morphology hypothesis, microscopy was first performed and images of cells
were evaluated. Treatment with IFN-γ/LPS induced J774A.1 macrophage cells from an M0 state
to an M1 phenotype, while IL-4, IL-10, or IL-13 induced macrophages from an M0 state to an M2
phenotype. After 18 hours, uninfected M1 macrophages appeared flattened, extended, irregularly
shapes, and contained visible intracellular vacuoles and were more strongly adherent compared to
M0 and M2 cells. M0 appeared rounded or elongated and M2 macrophages induced by IL-4 and
IL-13 showed some degree of cell elongation with the majority of cells appearing rounded. M2
macrophages induced by IL-10 were rounded at 18, 24, and 48 hours, with no evidence of
elongation. After 24 and 48 hours of polarization treatment, M1 macrophages demonstrated the
same morphological changes described above, although the irregular shape and intracellular
vacuoles were more pronounced. Uninfected M1 macrophages could be distinguished from
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uninfected M2 macrophages by morphology, while uninfected M2 macrophages induced by either
IL-4 or IL-13 could not be differentiated from each other.
These findings agree with those reported in a study by McWhorter et al. (2013) where
changes in cellular morphologies in a bone marrow-derived macrophage (BMDMs) cell line were
observed when treated with either LPS and INF-γ or IL-4 and IL-13 for 24 hours induced M1 and
M2 macrophages, respectively. Similarly, a study by Sheng et al. (2011) found that LPS and IFNγ treated mouse BV-2 microglial cells and primary microglia displayed alterations in cell shape
and increases in cell death (determined using MTT assay). These effects also correlated with the
induction of NO after 24 hours of treatment, suggesting that the cytotoxicity was a result of NO
induction (Sheng et al., 2011). IFN-γ and TNF-α were also found to stimulate cell death in M1
macrophages (Kyoungho et. al., 2001). The present study also found that cell viability following
polarization at different time points was significantly reduced for M1 macrophages compared to
M0 macrophages; TNF-α expression was increased although NO was not measured. Additionally,
the decrease in viability in M1 macrophages occurred regardless of whether the macrophages were
uninfected or infected with HSV-1. M2 macrophages, regardless of method of induction,
demonstrated minor, although insignificant, reductions in viability compared with M0
macrophage.
Differences in J774A.1 macrophages cell morphology were noticed between uninfected,
polarized cells and uninfected, unpolarized cells, but not between HSV-1-infected M0, M1 and
M2 macrophages that all became rounded and aggregated with viral infection, as described by
Reichard (2012). These virus-induced morphological changes made it impossible to distinguish
between M1 and M2 phenotypes on the basis of morphology alone, since infected M1 and M2
cells appeared identical. However, infected M1 macrophages displayed a different morphology

57

compared to that of an uninfected M1 macrophages. Uninfected M1 cells were flattened, displayed
extended irregular shapes, and contained intracellular vacuoles; HSV-1 infected M1 macrophages
were rounded. These morphological changes are likely a result of alterations in the actin
cytoskeleton that occur during the normal virus life cycle (Bigley, 2014; Reichard, 2012). Overall,
these results for 18 and 48 hours are in agreement with the observations at 24 hours made by
Reichard (2012). Additionally, Li et al. (2005) noticed that an HSV-1 infected human cell lines
displayed few rounded cells 4 hours post-infection while almost all the cells became rounded with
1 to 3 days of infection. Cell viabilities were further reduced in HSV-1 infected M0 and M1
macrophages, as well as in infected M2 macrophages (induced by IL-4, IL-10, and IL-13) after 18,
24, and 48 hours compared to uninfected polarized macrophages. These observations suggest that
the effects of HSV-1 infection supersede the effects of polarization, and that the viral infection
itself causes cytotoxicity and changes in cell morphology that are indistinguishable among the
macrophage phenotypes (i.e., M0 vs. M1 vs. M2).
A study by Ambarus et al. (2012) used flow cytometry and quantitative RT-PCR to identify
CD markers following incubation of human monocyte-derived macrophages without or with
cytokines IFN-γ, IL-4, and IL-10 for 4 days. They found that CD80 expression levels were specific
(i.e., highest expression compared to other polarized macrophage populations) to M1 macrophages
exposed to IFN-γ; however, CD163 and CD200R were up-regulated in M2 macrophages induced
by IL-4 and IL-10, respectively. Similarly, IL-13 up-regulated CD200R. CD80 expression was
slightly, but not significantly, down-regulated on uninfected M1 macrophages and M2
macrophages activated by IL-4, IL-10, and IL-13 compared to uninfected M0 macrophages. Based
on these observation, we expected to observe up-regulation of CD80 expression on M1 murine
macrophages and down regulation of CD80 in M2 subsets. Our’s was an unexpected result given
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that CD80 is antigen stumilation co- factor as is CD86. CD86 expression was up-regulated in
uninfected M1 polarized J774A.1 macrophages compared to uninfected M2 polarized cells
(Reichard, 2012). Infected M1 macrophages and M2 macrophages stimulated by IL-10 also
exhibited a minor increase in CD80 expression.
Reichard (2012) also found that CD86 expression was reduced in HSV-1 infected J774A.1
macrophages, while this study found that CD80 expression was slightly, but not significantly
increased in infected J774A.1 cells. While one study using Toxoplamsa gondii had found that
monocytes quickly up-regulated CD80 and CD86 early during infection (Subauste et al., 1998),
others have found that expression of CD80 is difficult to associate with CD86, since the latter is
expressed first and at greater levels than CD80 (Lenschow et al., 1994). Therefore, the link
between the CD86 observed by Reichard (2012) cannot predict or assume the presence of CD80.
CD163 is used as a marker for the M2 phenotype. IL-10 was found to cause an upregulation of CD163 on M2 human macrophages (Ambarus et al., 2012) while IFN-γ and LPS
were found to down-regulate CD163 expression (Buechlelr et al., 2000). Based on these
observation, we predict CD163 expression will be up-regulated on M2 murine macrophages
induced by IL-10 and down regulated on M1 macrophages. There was an increase in the level of
CD163 in infected M2 macrophages compared to uninfected M2 macrophage cells. Further, a
greater abundance of CD163 was detected on infected M2 macrophages induced by IL-10
compared to infected M2 macrophages induced by IL-4 and IL-13 (not statistically significant).
This increase may be a result of the ant-inflammatory response of M2 cells associated with HSV1 infection. This is suggested based on the fact that CD163 expression was increased on the surface
of monocytes of human immunodeficiency virus (HIV) patients, indicating that it may play a role
in the immune response to limit inflammation (Tippett et al., 2011). Conversely, reducing the
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levels of CD163 limits the anti-inflammatory effects, resulting in pro-inflammatory conditions that
help to destroy virus infected cells (Tuluc et al., 2014). A reduction of CD163 expression on M1
macrophages uninfected or infected with HSV-1 indicates that CD163 is a marker for M2
macrophages (although not significantly different), specifically in M2 macrophages induced by
IL-10. A recent study done by Jaguin et al, 2013 indicated that CD206 macrophage mannose
receptor marker expression on human macrophages was not able to discriminate between M1 and
M2 populations, similar to observations in murine RAW264.7 cells (Reichard, 2014).
We did not observe the expected results. This may have been due to limited sampling
numbers, species-dependent differences (human vs. mice), sensitivity of technique/approach, and
sub-culturing of macrophage cell lines that may have led to the loss of gene expression and/or
impaired immune function. Therefore, increasing the sample number and isolating fresh cells may
have helped to achieve statistically significant results.
The third CD marker evaluated in this study, CD200R, an immune-inhibitory
receptor to prevent inflammatory macrophage activation (Hoek et al., 2000). Similar to CD163,
CD200R expression induces an anti-inflammatory response that helps to control pro-inflammatory
responses by limiting pro-inflammatory cytokine secretion (Jenmalm et al., 2006). We expected
to observe up-regulation of CD200R expression on M2 murine macrophages induced by IL-4 or
IL-13. In this study, the only statistically significant difference in CD200R expression occurred
between HSV-1 infected M0 and HSV-1 infected M2 macrophages induced by IL-13 (17% versus
28% of the population, respectively). Increasing the levels of CD200R expression in M2
RAW264.7 macrophages may halt the pro-inflammatory signaling pathway (Albeshri, 2014).
Ambarus et al. (2012) showed that CD200R expression was specific for M2a macrophages induced
by either IL-4 or IL-13. When human cells are stimulated with IL-4, IL-13, or IL-10 for 3 days in
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vitro, an increase (not significant in the case of IL-10) in CD 200R expression occurred with even
greater expression of CD200R after 7 days infection by T. crassiceps (Koning et al., 2010). The
data described here are also in agreement with the observations of Jaguin et al., (2013) that reported
that CD200R expression was unique to the M2 polarized human macrophages treated with IFN-γ,
LPS and IL-4 also used in this study. These CD markers are summarized in (Figure 29).

Figure 29: Summary of the CD markers examined in this study (CD80, CD163, CD200R) and that
of Reichard (2012) (CD14, CD206, CD86).
SOCS proteins work as feedback inhibitors for cytokines signaling through the JAK/STAT
pathway that regulates inflammatory responses in macrophages (Yoshimura et al., 2005).
Reichard (2012) reported that uninfected J774A.1 M1 cells expressed higher levels of SOCS1 than
SOCS3 with a SOC1/SOCS3 ratio of 7:1 at 24 hours after polarization. HSV-1-infected M1 cells
expressed a SOCS1/SOCS3 ratio of 1:1 while M2-infected cells exhibited a SOCS1/SOCS3 ratio
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of 1:2. SOCS3 represses the M1 pro-inflammatory murine macrophage phenotype, reducing the
macrophage inflammatory responses (Qin and others 2012a). Qasimi et al. (2006) showed that
SOCS3 protein mediates IL-10 inhibition of TNF-α and nitric oxide production. IL-10 was
responsible for the anti-inflammatory response to Borrelia burgdorferi in this same macrophage
cell line (J774A.1) (Dennis et al., 2006). Based on these published studies, we hypothesized that
the HSV-1-infected J774A.1 M1 macrophages were attempting to counteract the effects of
inflammatory molecules induced by polarization by producing SOCS3.
Cell viabilities of polarized M1 and HSV-1-infected M1 J774A.1 macrophages were
determined following treatment with SOCS1 and SOCS3 peptide mimetics and pJAK2 for 24
hours. The SOCS3 peptide mimetic and pJAK2 peptide mimetic resulted in increased viability of
polarized M1 macrophages compared with SOCS1 treated cells. Production of TNF-α and IL-6
was reduced in polarized M1 macrophage treated with SOCS3 or pJAK2 peptide mimetic
compared with polarized M1 untreated cells. There were no differences in the level of IL-1β
produced between M1 untreated and M1 treated with either SOCS1, SOCS3, or pJAK2. Eigenbrod
et al. (2013) provided an explanation for the lack of IL-1 β production. They showed that M1 cells
induced by IFN-γ and LPS inhibited IL1β production. This observation correlates well with present
results in M1 cells (both RAW and J774A.1) treated with IFN-γ and LPS. IL-10 levels increased
two-fold, indicating an anti-inflammatory effect. The same result was observed by Qin et al. (2012)
where M1 cells with SOCS3 showed a decrease in the production of pro-inflammatory cytokines
TNF-α, IL-6 and an increase in the anti-inflammatory IL-10 compared to cells that were deficient
in SOCS3. The anti-inflammatory effect of SOCS3 is further supported by Jo et al. (2005) who
used a recombinant cell-penetrating form of SOCS3 (CP-SCS3) to protect mice (C3H/HeJ) from
the lethal effects of Staphylococcus enterotoxin B and LPS. Within 2 hours after injection, CP-
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SOCS3 was distributed in multiple organs, persisted for at least 8 hours, and reduced the
production of inflammatory cytokines.
Based on these observations and anti-inflammatory support for SOCS3 from the literature,
we tested whether the SOCS3 peptide mimetic could modify the cytotoxicity of the M1
polarization treatment or virus infection. When compared with the untreated controls, the SOCS3
peptide mimetic increased cell viability in the M1 and HSV-1-infected M1 cells, however, SOCS3
did not significantly affect HSV-1-infected M0 (unpolarized) cells. It appeared that the SOCS3
peptide mimetic protected the macrophages from the lytic effects of M1 polarization. The SOCS3
peptide mimetic showed no significant effect on HSV-1 infected, M1 polarized, or HSV-1 + M1treated J774 cells; however, the SOCS3 peptide mimetic increased cell viability in HSV-1-infected
M1 J774A.1 macrophages. No change was observed in IL-1β expression between M1, M1 treated
with SOCS3, and M2 macrophages. As discussed previously, IFN-γ used to polarized M1 cells
inhibits IL-1β expression (Eigenbrod et al., 2013)
Untreated M1 cells produce high levels of TNF-α and IL-6, while M1 cells treated with
SOCS3 peptide mimetic behaved similar to the M2 phenotype by producing the anti-inflammatory
cytokine IL-10. This result suggests that SOCS3 mimetic exerts an anti-inflammatory effect by
diminishing the lytic effect of M1 polarization. The mechanism behind SOCS3’s antiinflammatory effect likely depend on SOCS3 regulation of the STAT pathway responsible for
macrophage activation and M1 polarization (Qin et al., 2012).
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Future studies:
Macrophages are pivotal cells in inflammation and host defense; thus, alteration of
macrophage activity may prove a useful strategy for the treatment of certain diseases. Many
diseases, even those of a non-infectious nature, involve the activity of macrophages in generating
an inflammatory response that wreak havoc on the human body. For instance, an imbalance
between M1 and M2 phenotypes is related to neurodegenerative diseases (Tang and Le, 2015).
Significant inflammation is associated with neurodegenerative diseases, including Parkinson's
disease and Alzheimer's disease (AD). Changes in microglial phenotypes are associated with stage
and severity of these diseases; therefore, switching microglial cells between M1 and M2
phenotypes may provide a useful therapeutic approach.
In order to switch the microglial population to M2 (anti-inflammatory) macrophages, it
would be necessary to supply M2-inducing stimuli. It is not feasible to use injected cytokines,
given that cytokines do not pass the blood-brain barrier (Tang and Le, 2015). It would be necessary
to use certain chemical compounds, such as fasudil to induce M2 polarization or minocycline that
inhibits M1 polarization (Kobayashi et al., 2013; Zhang et al., 2013). Given that HSV-1 infection
has been shown to be a risk factor for AD later in life (Itzhaki, 2014), I propose to evaluate the
combined effect of HSV-1 with the polarizing-modifying chemicals fasudil or minocycline. I
would polarize microglial cells via stimulation with IFN-γ and LPS to induce the M1 state and IL4, IL-10 or IL-13 to induce the M2 state. I would then infect them with HSV-1 and treat them with
fasudil or minocycline and observe whether there is a shift in the cell population from the M1 to
the M2 phenotype. I would also assess viability (by haemocytometer or MTT assay), cell
morphology (observation under the light microscope) and cytokine production (by enzyme-linked
immunosorbent assay (ELISA) or Luminex Multiplex Immunoassays) to ensure there is a
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reduction in pro-inflammatory cytokines in M1 cells as the population is shifted to the antiinflammatory M2 state.
A separate line of interesting research also stems from the role of SOCS1 and SOCS3 in
the development and progression of AD. The present study showed that a SOCS3 peptide mimetic
was successful in reducing the amount of pro-inflammatory cytokines released by M1
macrophages. Therefore, one suggested approach for neurodegenerative diseases therapy is to
induce SOCS3 in microglial cells by gene therapy using delivery by a vector in order to decrease
the elevated levels pro-inflammatory cytokines and reduce inflammation.
Microtubule reorganization during HSV-1 infection facilitates the virus’ movement to and
from the host cell nucleus (Bigley, 2014). Therefore, determining the effect the SOCS3 on
microtubule structure of virus-infected cells would be an interest. An in vitro approach would
include inducing M1 macrophages treated with SOCS3 peptide (or leaving them untreated as a
control) with or without HSV-1 (MOI of 0.1) for 24 hours. After this time, changes in microtubules
would be evaluated. I would use an anti-mouse anti-alpha tubulin antibody as microtubule marker
(indirect immunofluorescence). In the SOCS3-treated and the virus-infected cells, I expect to see
fewer vacuoles resulting from the anti-inflammatory effect of SOCS3. I would expect that the
microtubule network in these macrophages treated with SOCS3 will be more stable (less disrupted)
than M1 infected cells.
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Figure S 1. Changes in Expression of CD80 in Uninfected, Un-polarized and Polarized
J774A.1 Macrophage following Cytokines Stimulation for 18, 24, 48 hours. Un-polarized and
cytokine-stimulated (polarized) macrophages were fixed and stained with Pacific blue conjugated
anti-mouse CD80 antibodies and then evaluated by immunofluorescence microscopy. M1
macrophages showed the highest expression levels of CD80 at 18 and 24 hours, whereas it was
down regulated at 48 hours. No apparent differences in the CD80 expression between these
macrophages at different points in time. (Scale bar =50μm).
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Figure S 2. Changes in Expression of CD80 in Un-polarized and Polarized J774A.1
Macrophage following Cytokines Stimulation and Infection with HSV-1 for 18, 24, 48 hours.
Infected, Un-polarized and cytokine-stimulated (polarized) macrophages were fixed and stained
xx

with Pacific blue conjugated anti-mouse CD80 antibodies and then evaluated by
immunofluorescence microscopy. Infected M1 macrophages showed an increase in CD80
expression at 24 and 48 hours. (Scale bar =50μm).
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Figure S 3. Changes in Expression of CD163 in Un-polarized and Polarized J774A.1
Macrophage following Cytokines Stimulation for 18, 24, 48 hours. Uninfected, Un-polarized
and cytokine-stimulated (polarized) macrophages were fixed and stained with FITC conjugated
anti-mouse CD163 antibodies and then evaluated by immunofluorescence microscopy. M2
macrophages induced by IL-10 or IL-13 showed higher expression of CD163 at 24 (for M2/IL-10)
and (18 hours for M2/IL-13). CD163 expression were down-regulated among macrophages. (Scale
bar =50μm).
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Figure S 4. Changes in Expression of CD163 in Un-polarized and Polarized J774A.1
Macrophage following Cytokines Stimulation and Infection with HSV-1 for 18, 24, 48 hours.
Infected, Un-polarized and cytokine-stimulated (polarized) macrophages were fixed and stained
with FITC conjugated anti-mouse CD163 antibodies and then evaluated by immunofluorescence
microscopy. Infected M2 macrophages polarized by IL-10 or IL-4 showed an up-regulation of
CD163 expression at 24 and 48 hours CD163 expression were down-regulated among
macrophages. (Scale bar =50μm).
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Figure S 5. Changes in Expression of CD200R in Un-polarized and Polarized J774A.1
Macrophage following Cytokines Stimulation for 18, 24, 48 hours. Infected, Un-polarized and

xxvi

cytokine-stimulated (polarized) macrophages were fixed and stained with Alexa Fluor 488
conjugated anti-CD200R antibodies and then evaluated by immunofluorescence microscopy.
Uninfected M2 macrophages polarized by IL-4 showed an up-regulation of CD200R expression
at 18 and 24 hours. No difference in CD200R expression were observed among macrophages.
(Scale bar =50μm).
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Figure S 6. Changes in Expression of CD200R in Un-polarized and Polarized J774A.1
Macrophage following Cytokines Stimulation and Infection with HSV-1 for 18, 24, 48 hours.
Infected, Un-polarized and cytokine-stimulated (polarized) macrophages were fixed and stained
xxviii

with Alexa Fluor 488 conjugated anti-CD200R antibodies and then evaluated by
immunofluorescence microscopy. CD200R expression was highly up-regulated in infected M2
macrophages induced by IL-13 at 24 hours, and slightly high in infected M2 macrophages induced
by IL-4 and IL-13 at 24 hours. (Scale bar =50μm).
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